NCT05618587View on ClinicalTrials.gov

Effect of Lithium Therapy on Long COVID Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

July 21, 2023

Study Completion Date

July 21, 2023

Conditions
Long COVID
Interventions
DRUG

Lithium

Lithium has multiple mechanisms of action including anti-inflammatory actions, which may be relevant for treating long COVID.

DRUG

Placebo

Inactive pill

Trial Locations (1)

14221

University at Buffalo, Williamsville

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

State University of New York at Buffalo

OTHER